Literature DB >> 9517649

Direct determination of colonic nitric oxide level--a sensitive marker of disease activity in ulcerative colitis.

D Rachmilewitz1, R Eliakim, Z Ackerman, F Karmeli.   

Abstract

OBJECTIVE: In active ulcerative colitis, colonic nitric oxide (NO) generation is enhanced and probably has an important role in its pathogenesis. We tested the reliability of an NO electrode in monitoring colonic NO levels in ulcerative colitis patients and control subjects and its possible usage as a marker of disease activity.
METHODS: Colonic NO level was determined by the NO detection system model NO-501 (InterMedical, Nagoya, Japan). The working electrode was inserted into a 7-mm diameter polyvinyl tube and introduced at a distance 6 cm from the anus. In each subject sigmoidoscopy was performed and mucosal biopsies were obtained. NO synthase (NOS) activity was determined by monitoring the conversion of 3H-arginine to citrulline.
RESULTS: Colonic NO level is significantly increased in patients with active ulcerative or Crohn's colitis--more than 2-fold higher than in control subjects. There was good correlation between colonic NO level and NOS activity and the clinical and endoscopic indices of disease activity.
CONCLUSION: Direct determination of colonic NO level is convenient, and reliable, and may help to monitor disease activity in ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9517649     DOI: 10.1111/j.1572-0241.1998.00409.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  17 in total

1.  Heparin-Coated Albumin Nanoparticles for Drug Combination in Targeting Inflamed Intestine.

Authors:  Sufeng Zhang; Won Joon Cho; Amy T Jin; Lie Yun Kok; Yunhua Shi; David E Heller; Young-Ah Lucy Lee; Yixuan Zhou; Xi Xie; Joshua R Korzenik; Jochen K Lennerz; Giovanni Traverso
Journal:  Adv Healthc Mater       Date:  2020-06-29       Impact factor: 9.933

Review 2.  Overview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseases.

Authors:  Imene Soufli; Ryma Toumi; Hayet Rafa; Chafia Touil-Boukoffa
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-08-06

Review 3.  Treatment of inflammatory bowel disease via green tea polyphenols: possible application and protective approaches.

Authors:  Sajid Ur Rahman; Yu Li; Yingying Huang; Lei Zhu; Shibin Feng; Jinjie Wu; Xichun Wang
Journal:  Inflammopharmacology       Date:  2018-03-12       Impact factor: 4.473

4.  NaOH-induced Crohn's colitis in rats: a novel experimental model.

Authors:  Erdem Koçak; Seyfettin Köklü; Erdem Akbal; Adnan Taş; Gökhan Karaca; Müzeyyen Hesna Astarcı; Berrak Güven; Murat Can
Journal:  Dig Dis Sci       Date:  2011-04-19       Impact factor: 3.199

5.  Bilirubin prevents acute DSS-induced colitis by inhibiting leukocyte infiltration and suppressing upregulation of inducible nitric oxide synthase.

Authors:  Stephen D Zucker; Megan E Vogel; Tammy L Kindel; Darcey L H Smith; Gila Idelman; Uri Avissar; Ganesh Kakarlapudi; Michelle E Masnovi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-09-17       Impact factor: 4.052

6.  Influence of the inducible nitric oxide synthase gene (NOS2A) on inflammatory bowel disease susceptibility.

Authors:  M Carmen Martín; Alfonso Martinez; J Luis Mendoza; Carlos Taxonera; Manuel Díaz-Rubio; Miguel Fernández-Arquero; Emilio G de la Concha; Elena Urcelay
Journal:  Immunogenetics       Date:  2007-10-23       Impact factor: 2.846

7.  Assessment of fractionated exhaled nitric oxide as a biomarker for the treatment of eosinophilic esophagitis.

Authors:  John Leung; Ann Nguyen-Traxler; Erika M Lee; Jason S Yip; Joel V Weinstock; Walter W Chan; Peter Ngo; Barbara J Weinstein; Peter A Bonis
Journal:  Allergy Asthma Proc       Date:  2012 Nov-Dec       Impact factor: 2.587

8.  The effect of iNOS inhibitors and hyperbaric oxygen treatment in a rat model of experimental colitis.

Authors:  Cemal Nuri Ercin; Zeki Yesilova; Ahmet Korkmaz; Ayhan Ozcan; Cagatay Oktenli; Ahmet Uygun
Journal:  Dig Dis Sci       Date:  2008-10-30       Impact factor: 3.199

9.  Altered cGMP dynamics at the plasma membrane contribute to diarrhea in ulcerative colitis.

Authors:  Kavisha Arora; Chandrima Sinha; Weiqiang Zhang; Chang Suk Moon; Aixia Ren; Sunitha Yarlagadda; Wolfgang R Dostmann; Adebowale Adebiyi; Yael Haberman; Lee A Denson; Xusheng Wang; Anjaparavanda P Naren
Journal:  Am J Pathol       Date:  2015-08-08       Impact factor: 4.307

10.  Poor Relationship Between Fractionated Exhaled Nitric Oxide and Disease Activity in Eosinophilic Esophagitis.

Authors:  Kimberly Johnson; Vivek Iyer; David Katzka; Karthik Ravi; Ryan Lennon; Richard Pendegraft; Debra Geno; Jeffrey Alexander
Journal:  Dysphagia       Date:  2018-07-24       Impact factor: 3.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.